Symptomatic treatment of pruritus;Traitement symptomatique du prurit

Annales de Dermatologie et de Venereologie

Volumn 132, Issue 5, 2005, Pages 492-495

  Misery, L ^a  

^a CHU MORVAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE 3' PHOSPHATE 5' PHOSPHOSULFATE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; BUFEXAMAC; BUTIX; BUTYROPHENONE; CALAMINE; CALENDULA EXTRACT; CAPSAICIN; CROTAMITON; DOLISOS; DOXEPIN; EMLA; FLUOXETINE; GABAPENTIN; GRANISETRON; HYDROXYZINE; MIZOLASTINE; NALTREXONE; NEUROLEPTIC AGENT; NISASEPTOL; NONSTEROID ANTIINFLAMMATORY AGENT; ONDANSETRON; PAROXETINE; PIMECROLIMUS; PO 12; PROMETHAZINE; PRURICED; QUINISOCAINE; RAFFINOSE; SEDAGEL; SEDAX; SERTRALINE; TACROLIMUS; TEFIRAX; TRIXERA; UNCLASSIFIED DRUG; XERAMANCE PLUS;

ARTICLE; HUMAN; PALLIATIVE THERAPY; PRURITUS; SYSTEMIC THERAPY; TOPICAL TREATMENT;

EID: 20044394535     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(05)79317-0     Document Type: Article

References (60)

1. Misery L, Cambazard F. Prurit (avec le traitement). Rev Prat 2002;52:1139-44.
2. Fleischer AB. The clinical management of itching. New York: The Parthenon Publishing Group, 2000:186.
3. Shuttleworth D, Hill S, Marks R, Connelly DM. Relief of experimentally induced pruritus with a novel eutectic mixture of local anesthesic agents. Br J Dermatol 1988;119:535-40.
4. Kopecky EA, Jacobson S, Bich MB, Hubley P, Palozzi L, Clarke HM. Safety and pharmacokinetics of EMLA in the treatment of postburn pruritus in pediatric patients. J Burn Care Rehabil 2001;22:235-42.
5. Yosipovitch C, Szolar C, Hui XY, Maibach H. Effect of topically applied menthol on thermal, pain and itch sensations and biophysical properties of the skin. Arch Dermatol Res 1996;288:245-8.
6. Grove G, Zerweck C. An evaluation of the moisturizing and anti-itch effects of a lactic acid and pramoxine hydrochloride cream. Cutis 2004;73:135-9.
7. Campech M, Gavroy JP, Ster F, Griffe, O, Téot, L, Chavoin, JP, et al. Etude de l'effet antiprurigineux du raffinose sur le tégument récemment épidermisé du grand brûlé. Brûlures 2002;11:219-22.
8. Misery L, Mazharian R, Teurquety L, Cambazard, F, Drouault, Y, Cognat, T, et al. Efficacité du Gel de Calamine dans le prurit anal. Nouv Dermatol 2004;23:7-9.
9. Kuypers DR, Claes K, Evenepeol P, Maes B, Vanrenterghem Y. A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy. Nephrol Dial Transplant 2004;19:1895-901.
10. Ständer S, Luger TA. Antipruritische Wirkung von Pimecrolimus und Tacrolimus. Hautarzt 2003;54:413-7.
11. Ellis CN, Berberian B, Sulica VI, Dodd VA, Jarratt MT, Katz HI, et al. A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol 1993;29:438-42.
12. Ständer S, Luger TA, Metze D. Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol 2001;44:471-8.
13. Breneman DL, Cardone JS, Blumsack RF, Lather RM, Searle EA, Pollack VE. Topical capsaicin for treatment of hemodialysis-related pruritus. J Am Acad Dermatol 1992;26:91-4.
14. Drake LA, Fallon JD, Sober A. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. J Am Acad Dermatol 1994;31:613-6.
15. Zhai H, Hannon W, Hahn GS, Harper RA, Pelosi A, Maibach H. Strontium nitrate decreased histamine-induced itch magnitude and duration in man. Dermatology 2000;200:244-6.
16. Ahluwalia P, Mac Gill JI, Church MK. Nedocromil sodium inibits hitamine-induced itch and flare in the skin. Br J Pharmacol 2001;132:613-6.
17. Willis EF, Clough GF, Church MK. Investigation into the mechanisms by which nedocromil sodium, frusemide and bumetanide inhibit the histamine-induced itch and flare response in human skin in vivo. Clin Exp Allergy 2004;34:450-5.
18. Thomsen JS, Simonsen L, Benfeldt E, Jensen SB, Serup J. The effect of topically applied salicylic compounds on serotonin-induced scratching behavior in hairless rats. Exp Dermatol 2002;11:370-5.
19. Yosipovitch G, Sugeng MW, Chan YH, Goon A, Ngim S, Goh CL. The effect of topically applied aspirin on localized circumscribed neurdermatitis. J Am Acad Dermatol 2001;45:910-3.
20. Smith EB, King CA, Baker MD. Crotamiton lotion in pruritus. Int J Dermatol 1984;23:684-5.
21. Vaatainen N, Hannuksela M, Karnoven J. Local photochemotherapy in nodular prurigo. Acta Derm Venereol 1979;59:544-7.
22. Hindson C, Taylor A, Martin A, Downey A. UVA light for relief of uremic pruritus. Lancet 1981;1:215.
23. Rosenthal E, Diamond E, Benderly A, Etzioni, A. Cholestatic pruritus: effect of photochemotherapy on pruritus and excretion of bile acids in urine. Acta Pediatrica 1994;83:888-91.
24. Menage HD, Norris PC, Hawk JL, Greaves MW. The efficacy of psoralen photochemotherapy in the treatment of aquagenic pruritus. Br J Dermatol 1993;129:163-5.
25. Gorin I, Lessana-Leibowitch M, Fortier P, Leibowitch J, Escande JP. Successful treatment of the pruritus of human immunodefiency virus infection and acquired immunodeficiency syndrome with psoralens plus ultraviolet A therapy. J Am Acad Dermatol 1989;20:511-3.
26. Crosby DL. Phototherapy for geriatric pruritus. J Geriatr Dermatol 1995;3:24-31.
27. Tan JKL, Haberman HF, Coldman AJ. Identifying effective treatments for uremic pruritus. J Am Acad Dermatol 1991;25:811-8.
28. Lundeberg T, Bondesson L, Thomas M. Effect of acupuncture on experimentally induced itch. Br J Dermatol 1987;117:771-7.
29. Monk BE. Transcutaneous electronic nerve stimulation in the treatment of generalized pruritus. Clin Exp Dermatol 1993;18:67-8.
30. Belgrade MJ, Solomon LM, Litcher EA. Effect of acupuncture on experimentally induced itch. Acta Derm Venereol 1984;64:129-33.
31. Nilsson HJ, Psouni E, Carstam R, Schouenborg J. Profound inhibition of chronic itch induced by stimulation of thin cutaneous nerve fibres. J Eur Acad Dermatol Venereol 2004;18:37-43.
32. Epstein E, Pinsky JB. A blind study. Arch Dermatol 1964;89:548-9.
33. Salo OP, Kauppinen K, Mannisto PT. Cimetidine increases the concentration of hydroxyzine. Acta Derm Venereol 1986;66:349-50.
34. Sugimoto Y, Iba Y, Nakamura Y, Kayasuga R, Kamei C. Pruritus-associated response mediated by cutaneous histamine H3 receptors. Clin Exp Allergy 2004;34:456-9.
35. Andersen LW, Friedberg M, Lokkegaard N. Naloxone in treatment of uremic pruritus. Clin Nephrol 1984;21:355-6.
36. Peer G, Kivity S, Agami O. Randomized cross-over trial of naltrexone in uraemic pruritus. Lancet 1996;348:1552-4.
37. Pauli-Magnus C, Mikus G, Alscher D, Kirschner T, Nagel N, Gugelen W, et al. Naltrexone does not relieve uraemic pruritus: Results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol 2000;11:514-9.
38. Legroux-Crespel E, Cledes J, Misery L. A comparative study on the effects of naltrexone and loratadine on uremic pruritus. Dermatology 2004;208:326-30.
39. Bergasa NV, Alling DW, Talbot TL, Wells MC, Jones EA. Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. J Am Acad Dermatol 1999;41:431-4.
40. Terg R, Coronel E, Sorda J, Munoz AE, Findor J. Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study. J Hepatol 2002;37:717-22.
41. Wolfhagen FHJ, Sternieri E, Hop WCJ, Vitale C, Bertoletti M, Van Buuren HR. Oral naltrexone treatment for cholestatic pruritus: a double blind, placebo-controlled study. Gastroenterology 1997;113:1264-9.
42. Heyer G, Groene D, Martus P. Efficacy of naltrexone on acetylcholine-induced alloknesis in atopic eczema. Exp Dermatol 2002;11:448-55.
43. Metze D, Reimann S, Luger TA. Effective treatment of pruritus with naltrexone, an orally active opiate antagonist. Ann N Y Acad Sci 1999;885:430-2.
44. Metze D, Reimann S, Beissert S, Luger TA. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. J Am Acad Dermatol 1999;41:533-9.
45. Kjellberg F, Tramer MR. Pharmacological control of opioid-induced pruritus: a quantitative systematic review of randomized trials. Eur J Anaesthesiol 2001;18:346-57.
46. Larijani GE, Goldberg ME, Rogers KH. Treatment of opoid-induced with ondansetron: report of four patients. Pharmacotherapy 1996;16:958-60.
47. Balaskas EV, Bamihas GI, Karamouzis M, Voiyatzis C, Tourkantonis A. Histamine and serotonine in uremi pruritus: effect of ondansetron in CAPD-pruritic patients. Nephron 1998;78:395-402.
48. Schwörer H, Ramadori G. Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists. Clin Investig 1993;71:659-62.
49. Ashmore SD, Jones CH, Newstead CG, Daly MJ, Chrystyn H. Ondansetron therapy for uremic pruritus in hemodialysis patients. Am J Kydney Dis 2000;35:827-831.
50. Murphy M, Reaich D, Pai P, Finn P, Carmichael AJ. A randomized, placebo-controlled, double-blind trial of ondansetron in renal itch. Br J Dermatol 2003;148:314-7.
51. Weisshaar E, Dunker N, Rohl FW, Gollnick H. Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients. Exp Dermatol 2004;13:298-304.
52. Silva SR, Viana PC, Lugon NV, Hoette M, Ruzany F, Lugon JR. Thalidomide for the treatment of uremic pruritus: A crossover randomized double-blind trial. Nephron 1994;67:270-3.
53. Maurer T, Poncelet A, Berger T. Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects. Arch Dermatol 2004;140:845-49.
54. Daly BM, Shuster S. Antipruritic action of thalidomide. Acta Derm Venereol 2000;80:24-5.
55. Winhoven SM, Coulson IH, Bottomley WW. Brachioradial pruritus: response to treatment with gabapentin. Br J Dermatol 2004;150:786-7.
56. Teofoli P, De Pita O, Frezzolini A, Lotti T. Antipruritic effect of oral cyclosporin A in essential senile pruritus. Acta Derm Venereol 1998;78:232.
57. Gupta MA, Gupta AK, Schork NJ, Ellis CN. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 1994;56:36-40.
58. Shenefelt PD. Biofeedback, cognitive-behavioral methods, and hypnosis in dermatology: is it all in your mind? Dermatol Ther 2003;16:114-22.
59. Browning JCB, Mayo MJ. Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol 2003;98:2736-41.
60. Zylicz Z, Krajnik M, Sorge AA, Costantini M. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage 2003;26:1105-12.